Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy

Last updated: June 25, 2024
Sponsor: Hospices Civils de Lyon
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gastroesophageal Reflux Disease (Gerd)

Esophageal Disorders

Heartburn (Pediatric)

Treatment

Wireless pH monitoring

Upper gastrointestinal (GI) endoscopy

pH-impedance monitoring

Clinical Study ID

NCT03596476
69HCL18_0043
2018-A01591-54
  • Ages > 18
  • All Genders

Study Summary

Gastro-esophageal reflux disease (GERD) is defined as the reflux of gastric content into the esophagus that causes troublesome symptoms or complications. Nine to 30% of the population suffers from GERD-suggestive symptoms (heartburn, regurgitation, chest pain, chronic couch, sore throat). In the absence of warning signs, proton pump inhibitors (PPI) are prescribed as first-line treatment. However, 20 to 60% of patients are unsatisfied because of persistent symptoms when taking PPI. Causes of persistent symptoms are: erroneous diagnosis of GERD (up to 50% of PPI non-responders), rumination syndrome, excessive weakly acid reflux on PPI due to defective esophago-gastric junction or an excessive number of transient lower esophageal sphincter relaxations (main mechanism of GERD), poor acid secretion inhibition on PPI, and non-compliance to therapy. Complementary examinations are indicated to explain persistent GERD symptoms. Upper gastro-intestinal endoscopy is performed first to rule out an esophageal tumor and to identify erosive esophagitis, a specific sign of GERD. However, it is normal in up to 70% of symptomatic GERD patients. Direct detection of reflux episodes is then requested to confirm GERD. The gold standard for reflux detection is the ambulatory measurement of esophageal pH for 24 to 96 hours using a catheter (catheter-based pH-monitoring) or a capsule clipped into the esophagus (wireless pH-monitoring). Reflux episodes are defined as an esophageal pH < 4. Another method of reflux detection is based on liquid and gas detection in the esophagus using pH-impedance monitoring. Recently the combination of impedance and esophageal pressure monitoring, called esophageal high resolution impedance manometry (HRIM) was introduced to simultaneously identify reflux episodes and their mechanisms. It has several advantages over esophageal pH measurement: shorter recording duration (1 or 2 hours post prandial) and identification of reflux mechanisms that might guide the choice of the best therapeutic option.

Hypothesis: The 1-hour post prandial esophageal HRIM might be useful to diagnose GERD.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient older than 18 years

  • Typical symptoms of GERD (heartburn, regurgitation) at least twice a week despitePPI therapy for at least one month.

  • Reflux Disease Questionnaire (RDQ) score off PPI > 3

  • Subject with health insurance

Exclusion

Exclusion Criteria:

  • Previous esophago-gastric surgery,

  • Previous history of developing esophageal or gastric tumor, esophageal stricture, oresophageal varices

  • Pregnancy (assessment at V0)

  • Contraindication to general anesthesia,

  • Contraindications to the wireless capsule pH-monitoring: pacemakers, implantablecardiac defibrillator,

  • Contraindications to HRIM: inability to tolerate nasal intubation, significantbleeding disorders for which nasal intubation is contraindicated, known esophagealobstruction is preventing the passage of the HRIM probe.

  • Intolerance or allergy to one component of the test meal,

  • Intolerance or allergy to PPI,

  • Inability to give consent,

  • Mentally unbalanced patients, under supervision or guardianship

  • Decline to participate in the study,

  • Participation in another study at the same time

Study Design

Total Participants: 330
Treatment Group(s): 4
Primary Treatment: Wireless pH monitoring
Phase:
Study Start date:
May 03, 2021
Estimated Completion Date:
May 03, 2027

Connect with a study center

  • Service d'Hepato-Gastroenterologie - Hôpital Trousseau - CHU de Tours

    Chambray-lès-Tours, 37171
    France

    Active - Recruiting

  • Service d'Hepato-Gastroenterologie - Hôpital Louis Mourier - APHP

    Colombes, 92700
    France

    Active - Recruiting

  • Service d'Explorations Fonctionnelles Digestives - Hôpital Edouard Herriot - HCL

    Lyon, 69437
    France

    Active - Recruiting

  • Service d'Hepato-Gastroenterologie - Hôtel Dieu - CHU de Nantes

    Nantes, 44093
    France

    Active - Recruiting

  • Service d'Hepato-Gastroenterologie - Hôpital Haut Lévêque - CHU de Bordeaux

    Pessac, 33600
    France

    Active - Recruiting

  • Service d'Hepato-Gastroenterologie - Hôpital Pontchaillou- CHU de Rennes

    Rennes, 35033
    France

    Active - Recruiting

  • Service de Physiologie Digestive, Respiratoire, Urinaire et Sportive - CHU de Rouen

    Rouen, 76031
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.